Radiation Injuries clinical trials
The registry lists 328 studies for Radiation Injuries across more than 10 countries. 96 are recruiting or about to start. 90 of them are mainly about Radiation Injuries (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 6 narrower conditions too, such as Cardiotoxicity: 818 studies, 234 open.
Get an email when these change. Save the Radiation Injuries studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Radiation Therapy Oncology Group (15) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (8) · University of Aarhus (7) · Wake Forest University Health Sciences (6) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (6) · Royal Marsden NHS Foundation Trust (5) · Alliance for Clinical Trials in Oncology (5) · National Taiwan University Hospital (4)
What is being tested here
Drugs under test in Radiation Injuries studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Hetrombopag | 2 | 0 | 2 |
| Bevacizumab | 1 | 1 | 4 |
| Chlorophyllin | 1 | 1 | 1 |
| Triamcinolone Acetonide | 1 | 1 | 1 |
| Triamcinolone | 1 | 1 | 1 |
| Lisinopril | 1 | 0 | 1 |
| Hetrombopag olamine | 1 | 0 | 1 |
| Lithium | 1 | 0 | 1 |
| Fucoidan | 1 | 0 | 1 |
| Cisplatin | 0 | 1 | 6 |
Drug classes tested here Angiogenesis inhibitors 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Apr 2027Traditional Chinese Medicine for the Prevention of Radiotherapy-Induced Oral Mucositis (RTOM) · Phase 3 · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Aug 2027Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal Carcinoma · Phase 3 · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Dec 2026Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy · Abramson Cancer Center at Penn Medicine
- Dec 2026Adaptive RadioTherapy for OroPharynx Cancer · Centre hospitalier de l'Université de Montréal (CHUM)
- Dec 2026Manual Lymph Drainage for External Lymphedema · Lund University
- Dec 2026Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT) · McGill University Health Centre/Research Institute of the McGill University Health Centre
- Dec 2026PRISM Trial: Partial Breast Versus Whole Breast Radiation in Early Breast Cancer · Jinnah Postgraduate Medical Centre
- Dec 2026ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer · Hospital Universitari de Bellvitge
- Dec 2026Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer · Institute of Oncology Ljubljana
- Feb 2027Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART) · IRCCS San Raffaele
Who these studies take
Of the 75 Radiation Injuries studies recruiting now, 51 (68%) set no upper age limit and 14 (19%) stop at 75 or younger. 8 (11%) take children under 18. 16 (21%) are for women only and 7 (9%) for men only; 2 (3%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 7 (9%) | 7 (9%) |
| 18 | 60 (80%) | 53 (71%) |
| 30 | 61 (81%) | 55 (73%) |
| 40 | 62 (83%) | 55 (73%) |
| 50 | 63 (84%) | 55 (73%) |
| 65 | 65 (87%) | 56 (75%) |
| 75 | 59 (79%) | 50 (67%) |
| 85 | 54 (72%) | 48 (64%) |
Across all 328 studies, recruiting or not: 18% stop at 75 or younger and 7% at 65; 14% take children; 21% are for women only and 9% for men only; 6% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Radiation Injuries studies take
Of 72 interventional studies with no phase under Radiation Injuries, half reached primary completion within 50 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 50 mo24–116 · 72 studies | — | 43 mo24–116 · 69 studies |
| Observational | 74 mo35–189 · 55 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting1
- Health Oriented Protocol for Epidermal RadiodermatitisOct 14, 2026NCT07129525
Newly registered3
- Risk-Adapted Segmental Esophagus-Sparing Radiotherapy for Definitive Non-Small Cell Lung CancerNov 2, 2026NCT07908732
- Determinants of Radiation Dermatitis in Head and Neck Cancer Patients Receiving Preventive PhotobiomodulationOct 28, 2026NCT07899866
- Oral Care Program for Mouth Side Effects During Head and Neck Radiation TherapyOct 21, 2026NCT07885033
Studies
Recruiting first, then most recently updated. Showing 50 of 328. Browse all 328 → or search them.
- Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT07761910Phase 21 country
- Risk-Adapted Segmental Esophagus-Sparing Radiotherapy for Definitive Non-Small Cell Lung CancerNot yet recruitingNCT07908732Phase 3
- Determinants of Radiation Dermatitis in Head and Neck Cancer Patients Receiving Preventive PhotobiomodulationNot yet recruitingNCT078998661 country
- PRISM Trial: Partial Breast Versus Whole Breast Radiation in Early Breast CancerNot yet recruitingNCT07811635Not applicable3 countries
- Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)RecruitingNCT063061701 country
- Oral Care Program for Mouth Side Effects During Head and Neck Radiation TherapyNot yet recruitingNCT07885033Not applicable1 country
- Health Oriented Protocol for Epidermal RadiodermatitisRecruitingNCT071295251 country
- Study on Prostate Salvage Using High-dose-rate BrachytherapyRecruitingNCT078605281 country
- The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled StudyRecruitingNCT04700527Phase 1/21 country
- Gut Microbiome in Gynecological Cancer Patients With Pelvic Toxicity: Controls Versus Ozone Treatment. (MicrOzoGineTox)RecruitingNCT072596811 country
- A Study of Chlorophyllin or Placebo With Standard Treatment for Late Radiation Induced Luminal Gastrointestinal Tract BleedingNot yet recruitingNCT07837713Phase 31 country
- Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2026 and 2029.RecruitingNCT073258511 country
- Pre-Rehabilitation for Female Patients Undergoing Pelvic RadiotherapyRecruitingNCT06059586Not applicable1 country
- ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast CancerRecruitingNCT04889924Not applicable2 countries
- Evaluation of Technological Innovation in RadiotherapyRecruitingNCT033788561 country
- Adaptive RadioTherapy for OroPharynx CancerRecruitingNCT04901234Phase 22 countries
- Microbiome Determinants of Adverse Effects of Stereotactic RadiosurgeryRecruitingNCT077679811 country
- Attribution of Toxicities Due to Radiotherapy and Immuno-Biological TherapiesRecruitingNCT041152671 country
- Vitamin D Status and Clinical Outcomes in Locally Advanced Cervical CancerRecruitingNCT077439181 country
- Retrospective Observational Study of Oral Complications and Quality of Life in Head and Neck Cancer Patients Treated With Radiotherapy or Chemoradiotherapy.Not yet recruitingNCT077397711 country
- A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate CancerRecruitingNCT05530655Early Phase 11 country
- Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain MetastasesRecruitingNCT06888817Phase 31 country
- Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.RecruitingNCT07483658Not applicable1 country
- Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.RecruitingNCT06758830Phase 2/31 country
- CPAP or BiPAP for Motion Mitigation During RadiotherapyRecruitingNCT04986293Not applicable1 country
- Pseudomembrane Removal for Post-RT Nasopharyngeal NecrosisNot yet recruitingNCT07552883Not applicable
- Traditional Chinese Medicine for the Prevention of Radiotherapy-Induced Oral Mucositis (RTOM)Not yet recruitingNCT07543978Phase 3
- Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs.RecruitingNCT05635929Not applicable1 country
- Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK)Not yet recruitingNCT07528339
- Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First YearsRecruitingNCT06618703Not applicable1 country
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruitingNCT040753059 countries
- Curatively Intended Thoracic ReirradiationRecruitingNCT069500731 country
- Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target VolumeRecruitingNCT06719440Not applicable1 country
- Early Diagnosis and Cardiovascular Risk Stratification in Children Exposed to Cancer TherapiesNot yet recruitingNCT07408362Not applicable
- Preoperative Hypofractionated RT + Immunotherapy & Surgery for Retroperitoneal Sarcoma (FUSION-02)Not yet recruitingNCT07396116Not applicable1 country
- Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic RadiationRecruitingNCT07231588Early Phase 11 country
- DENTOFACIAL-PBT Stage 2 - Feasibility StudyEnrolling by invitationNCT070572841 country
- RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3RecruitingNCT06297902Not applicable1 country
- Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)RecruitingNCT05224934Not applicable1 country
- MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)RecruitingNCT05183074Not applicable1 country
- The Radiation ProtEction for Dose RedUction in the Cardiac CathEter Lab Study: The REDUCE TrialRecruitingNCT06875583Not applicable1 country
- Manual Lymph Drainage for External LymphedemaRecruitingNCT07215169Not applicable1 country
- Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal CarcinomaNot yet recruitingNCT07189572Phase 3
- Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.RecruitingNCT05786742Not applicable1 country
- Longitudinal Registry Including Patients Treated With Heavy ParticlesRecruitingNCT052032501 country
- Quantifying Radiation Induced Vaginal StenosisRecruitingNCT050027511 country
- Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:RecruitingNCT06036706Not applicable1 country
- Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual TumorRecruitingNCT06311955Phase 21 country
- Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly PatientsRecruitingNCT06311981Phase 21 country
- The Clinical Study of Post-operative Proton Radiotherapy for Thymus TumorRecruitingNCT06311968Phase 21 country